Assessment of the 2006 revised antiphospholipid syndrome classification criteria

被引:68
作者
Kaul, Mala
Erkan, Doruk
Sammaritano, Lisa
Lockshin, Michael D.
机构
[1] Cornell Univ, Weill Med Coll, New York, NY USA
[2] Hosp Special Surg, New York, NY 10021 USA
关键词
D O I
10.1136/ard.2006.067314
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To analyse antiphospholipid ( aPL) antibody- positive patients using the 2006 revised antiphospholipid syndrome ( APS) classification criteria. Methods: A descriptive study of 200 aPL- positive patients identified in a local, hospital- based registry, analysing demographic, clinical and aPL characteristics. Patients were analysed for ( 1) fulfilment of the 1999 original ( Sapporo) and 2006 revised APS classification criteria; ( 2) non- criteria aPL features ( for all aPLpositive patients, based on the 2006 revised criteria definitions); and ( 3) non- aPL thrombosis risk factors at the time of the clinical events ( for patients with APS, based on the 2006 revised criteria stratifications). Results: Of the 200 patients, 183 patients had sufficient data for analysis. Of these, 39 ( 21%) patients did not meet the laboratory requirement of the original 1999 criteria. Of 81 patients with APS who met the 1999 classification criteria, 47 ( 58%) also met the 2006 revised criteria. Of 63 asymptomatic ( no vascular or pregnancy events) aPL- positive patients who met the laboratory requirement of the 1999 classification criteria, 38 ( 60%) also met the laboratory requirement of the 2006 revised criteria. More than 50% of the patients with APS with vascular events had identifiable non- aPL thrombosis risk factors at the time of clinical events. Conclusions: Only 59% of the patients meeting the 1999 APS Sapporo classification criteria met the 2006 APS classification criteria. The revised criteria will have positive implications in APS research by way of limiting the inclusion of a heterogeneous group of patients and also by way of providing a risk- stratified approach.
引用
收藏
页码:927 / 930
页数:4
相关论文
共 9 条
[1]   Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002 [J].
Brey, RL ;
Chapman, J ;
Levine, SR ;
Ruiz-Irastorza, G ;
Derksen, RHWM ;
Khamashta, M ;
Shoenfeld, Y .
LUPUS, 2003, 12 (07) :508-513
[2]  
ERKAN D, 2004, THROMB RES, V114, pP618
[3]   What is antiphospholipid syndrome? [J].
Erkan D. ;
Lockshin M.D. .
Current Rheumatology Reports, 2004, 6 (6) :451-457
[4]  
Girón-González JA, 2004, J RHEUMATOL, V31, P1560
[5]   International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) [J].
Miyakis, S ;
Lockshin, MD ;
Atsumi, T ;
Branch, DW ;
Brey, RL ;
Cervera, R ;
Derksen, RHWM ;
De Groot, PG ;
Koike, T ;
Meroni, PL ;
Reber, G ;
Shoenfeld, Y ;
Tincani, A ;
Vlachoyiannopoulos, PG ;
Krilis, SA .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (02) :295-306
[6]   Clinical relevance of the recent update of the classification criteria for definite antiphospholipid syndrome: an obstetric medicine clinic series of 107 patients [J].
Pourrat, O. ;
Jollit, C. ;
Gombert, J. M. ;
Boinot, C. ;
Pierre, F. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (10) :2276-2277
[7]  
Roubey RAS, 2004, ARTHRITIS RHEUM, V50, pS640
[8]  
Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO
[9]  
2-F